TABLE 5.
Admission and outcome characteristics of children admitted under new criteria stratified by admission MUAC1
| MUAC |
|||||
| <90 mm | 90 to <100 mm | 100 to <110 mm | 110 to <115 mm | Total | |
| Children admitted, n (%) | 115 | 361 | 1330 | 2595 | 4401 |
| Sex, n (%) | |||||
| F | 76 (66.1) | 264 (73.1) | 899 (67.6) | 1702 (65.6) | 2941 (66.8) |
| M | 39 (33.9) | 97 (26.9) | 431 (32.4) | 893 (34.4) | 1460 (33.2) |
| Age (mo), n (%) | |||||
| 6–11 | 74 (64.9) | 166 (46.0) | 559 (42.0) | 768 (29.6) | 1567 (35.6) |
| 12–23 | 30 (26.3) | 151 (41.8) | 600 (45.1) | 1377 (53.1) | 2158 (49.0) |
| 24–35 | 7 (6.1) | 29 (8.0) | 121 (9.1) | 326 (12.6) | 483 (11.0) |
| 36–59 | 3 (2.6) | 15 (4.2) | 50 (3.8) | 124 (4.8) | 192 (4.4) |
| Age, mo | 9 (7–12)2 | 12 (8–18) | 12 (9–18) | 12 (10–18) | 12 (10–18) |
| Nutritional status at admission | |||||
| MUAC, mm | 82.4 ± 9.13 | 95.2 ± 2.8 | 105.2 ± 2.7) | 112.6 ± 1.6 | 108.2 ± 7.2 |
| WHO WHZ | −4.5 ± 1.3 | −4.0 ± 1.1 | −3.3 ± 0.9 | −2.9 ± 0.7 | −3.1 ± 0.9 |
| WHZ <−3 at admission, % | 90.3 | 84.4 | 67.9 | 43.2 | 55.2 |
| WHO HAZ | −5.5 ± 1.7 | −4.6 ± 1.6 | −3.9 ± 1.5 | −3.3 ± 1.4 | −3.7 ± 1.5 |
| Admitted to SC during ATFC treatment, n (%) | 21 (18.3) | 53 (14.7) | 123 (9.2) | 159 (6.1) | 356 (8.1) |
| Direct referral to SC at admission, n (%) | 11 (9.6) | 7 (1.9) | 6 (0.5) | 9 (0.3) | 33 (0.7) |
| Outcome, n (%) | |||||
| Defaulter | 59 (51.3) | 175 (48.5) | 584 (43.9) | 773 (29.8) | 1591 (36.2) |
| Nonresponder | 5 (4.3) | 34 (9.4) | 102 (7.7) | 107 (4.1) | 248 (5.6) |
| Death | 8 (7.0) | 6 (1.7) | 11 (0.8) | 11 (0.4) | 36 (0.8) |
| Cured | 43 (37.4) | 146 (40.4) | 633 (47.6) | 1704 (65.7) | 2526 (57.4) |
| Nutritional status at discharge of children discharged as cured | |||||
| Attained ≥15% of body weight, n (%) | 43 (100) | +145 (99.3) | 561 (88.6) | 671 (39.4) | 1420 (56.2) |
| MUAC, mm | 122.0 ± 1.3 | 122.9 ± 3.1 | 123.0 ± 2.5 | 123.2 ± 2.3 | 123.1 ± 2.4 |
| WHO WHZ | −0.7 ± 0.9 | −1.1 ± 1.1 | −1.4 ± 0.8 | −1.6 ± 0.7 | −1.5 ± 0.8 |
| WHZ <−3 at discharge, n (%) | 1 (2.3) | 3 (2.1) | 7 (1.1) | 46 (2.7) | 57 (2.3) |
| WHZ <−2 at discharge, n (%) | 3 (7.0) | 28 (19.2) | 128 (20.3) | 463 (27.2) | 622 (24.6) |
| WHO HAZ | −5.0 ± 1.4 | −4.6 ± 1.4 | −4.1 ± 1.4 | −3.5 ± 1.4 | −3.7 ± 1.4 |
| Treatment-response indicators (cured) | |||||
| Weight gain, g · kg−1 · d−1 | 7.5 ± 3.0 | 6.6 ± 4.4 | 5.1 ± 2.9 | 4.9 ± 3.8 | 5.1 ± 3.7 |
| Length of stay, wk | 15.3 ± 8.0 | 12.4 ± 7.6 | 9.0 ± 5.9 | 6.0 ± 4.5 | 7.3 ± 5.6 |
| Length of stay, wk | 13.3 (9.1–20.6) | 11.0 (7.0–15.8) | 7.9 (5.0–11.1) | 4.7 (3.0–7.3) | 6.0 (3.3–9.3) |
| MUAC gain, mm/d | 0.44 ± 0.20 | 0.43 ± 0.26 | 0.39 ± 0.26 | 0.40 ± 0.32 | 0.40 ± 0.30 |
| Height/length gain, cm/wk | 0.30 ± 0.18 | 0.22 ± 0.39 | 0.17 ± 0.19 | 0.13 ± 0.41 | 0.15 ± 0.36 |
1
ATFC, Ambulatory Therapeutic Feeding Center; HAZ, height-for-age z score; MUAC, midupper arm circumference; SC, Stabilization Center; WHZ, weight-for-height z score.
2
Median; IQR in parentheses (all such values).
3
Mean ± SD (all such values).